SCHEMBL31069724

SCHEMBL31069724

O=C1c2cc(B(O)O)cnc2CCCN1Cc1cc(OC(F)(F)F)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH1 Q13686 1/20 0.38
PRMT5 O14744 2/20 0.37
WDR77 Q9BQA1 2/20 0.37
RORC P51449 1/20 0.37
SCN1A P35498 1/20 0.35
SCN4A P35499 1/20 0.35
KCNH2 Q12809 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
HRH3 Q9Y5N1 2/20 0.34
GRM2 Q14416 1/20 0.34
ABL1 P00519 1/20 0.34
CXCR2 P25025 2/20 0.34
SSTR5 P35346 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31069723 0.86 ALKBH1 (0.37) ALKBH1PRMT5WDR77RORCSCN1A
SCHEMBL30483666 0.82 SCN1A (0.44) ALKBH1PRMT5WDR77RORCSCN1A
SCHEMBL29714020 0.81 SCN1A (0.38) ALKBH1RORCSCN1ASCN4AKCNH2
SCHEMBL22470576 0.81 SCN1A (0.38) ALKBH1RORCSCN1ASCN4AKCNH2
SCHEMBL25380728 0.78 TNIK (0.40) RORCSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069734 0.78 TNIK (0.40) RORCSCN1ASCN4AKCNH2SCN5A
SCHEMBL29846847 0.76 SCN1A (0.45) RORCSCN1ASCN4AKCNH2SCN5A
SCHEMBL29846809 0.74 CXCR2 (0.38) ALKBH1RORCSCN1ASCN4AKCNH2
SCHEMBL23753772 0.74 CXCR2 (0.38) ALKBH1RORCSCN1ASCN4AKCNH2
SCHEMBL30130638 0.73 HRH3 (0.45) PRMT5WDR77RORCSCN1ASCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556044-A Fused heterocyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-27 CN disclosed